Drug Profile
Research programme: metabotropic glutamate receptor agonists - Prescient NeuroPharma
Latest Information Update: 24 Apr 2007
Price :
$50
*
At a glance
- Originator Prescient NeuroPharma
- Class Small molecules
- Mechanism of Action Glutamate agonists; Metabotropic glutamate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 17 Oct 2001 Preclinical development for Neurological disorders (Prevention) in Canada (Unknown route)